Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors

Immunology and Cell Biology

Volumn 94, Issue 1, 2016, Pages 39-51

  Sreeramkumar, Vinatha ^a,d   Hons, Miroslav ^b,e   Punzón, Carmen ^a   Stein, Jens V ^b   Sancho, David ^c   Fresno, Manuel ^a   Cuesta, Natalia ^a,d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF BERN   (Switzerland)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^e INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; PROSTAGLANDIN E RECEPTOR 2; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTHRITIS; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; MOUSE; MULTIPHOTON MICROSCOPY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL COMMUNICATION; CROSS PRESENTATION; DISEASE MODEL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; ARTHRITIS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CROSS-PRIMING; DENDRITIC CELLS; DINOPROSTONE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-2; LYMPH NODES; MICE, KNOCKOUT; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; UP-REGULATION;

EID: 84983158175     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2015.62     Document Type: Article

References (33)

1. Tilley SL, Coffman TM, Koller BH. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15-23.
2. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-150.
3. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002; 2: 787-795.
4. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 2007; 282: 11613-11617.
5. Alfranca A, Iniguez MA, Fresno M, Redondo JM. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases. Cardiovasc Res 2006; 70: 446-456.
6. Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009; 206: 535-548.
7. Chemnitz JM, Driesen J, Classen S, Riley JL, Debey S, Beyer M et al. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in hodgkin's lymphoma. Cancer Res 2006; 66: 1114-1122.
8. Naito Y, Endo H, Arai K, Coffman RL, Arai N. Signal transduction in th clones: Target of differential modulation by PGE2 may reside downstream of the PKC-dependent pathway. Cytokine 1996; 8: 346-356.
9. Chen Q, Muramoto K, Masaaki N, Ding Y, Yang H, Mackey M et al. A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br J Pharmacol 2010; 160: 292-310.
10. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 2009; 15: 633-640.
11. Iniguez MA, Punzon C, Fresno M. Induction of cyclooxygenase-2 on activated T lymphocytes: Regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol 1999; 163: 111-119.
12. Kundu N, Ma X, Holt D, Goloubeva O, Ostrand-Rosenberg S, Fulton AM. Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function. Breast Cancer Res Treat 2009; 117: 235-242.
13. Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007; 67: 4507-4513.
14. Cope AP. T cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10 (Suppl 1): S1.
15. Honda T, Segi-Nishida E, Miyachi Y, Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 2006; 203: 325-335.
16. Myers LK, Kang AH, Postlethwaite AE, Rosloniec EF, Morham SG, Shlopov BV et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 2000; 43: 2687-2693.
17. Sreeramkumar V, Fresno M, Cuesta N. Prostaglandin E2 and T cells: Friends or foes? Immunol Cell Biol 2012; 90: 579-586.
18. Nombela-Arrieta C, Lacalle RA, Montoya MC, Kunisaki Y, Megías D, Marqués M et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 2004; 21: 429-441.
19. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26: 1511-1518.
20. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003; 171: 6173-6177.
21. Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, Maini RN. Dynamics of proinflammatory cytokine expression in the joints of mice with collageninduced arthritis (CIA). Clin Exp Immunol 1997; 107: 507-512.
22. Diaz-Munoz MD, Osma-Garcia IC, Fresno M, Iniguez MA. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-Activated macrophages. Biochem J 2012; 443: 451-461.
23. Chizzolini C, Chicheportiche R, Alvarez M, de Rham C, Roux-Lombard P, Ferrari-Lacraz S et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 2008; 112: 3696-3703.
24. Sakata D, Yao C, Narumiya S. Prostaglandin E2, an immunoactivator. J Pharmacol Sci 2010; 112: 1-5.
25. Li H, Edin ML, Gruzdev A, Cheng J, Bradbury JA, Graves JP et al. Regulation of T helper cell subsets by cyclooxygenases and their metabolites. Prostaglandins Other Lipid Mediat 2013; 104-105: 74-83.
26. Mahic M, Yaqub S, Johansson CC, Tasken K, Aandahl EM. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 2006; 177: 246-254.
27. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009; 229: 12-26.
28. Baratelli F, Lin Y, Zhu L, Yang SC, Heuzé-Vourc'h N, Zeng G et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 2005; 175: 1483-1490.
29. Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res 2005; 65: 5211-5220.
30. Lee BP, Juvet SC, Zhang L. Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells. Int Immunopharmacol 2009; 9: 534-539.
31. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002; 110: 651-658.
32. Feldmann M, Elliott MJ, Woody JN, Maini RN. Anti-tumor necrosis factor-Alpha therapy of rheumatoid arthritis. Adv Immunol 1997; 64: 283-350.
33. Martin P, Villares R, Rodriguez-Mascarenhas S, Zaballos A, Leitges M, Kovac J et al. Control of T helper 2 cell function and allergic airway inflammation by PKCzeta. Proc Natl Acad Sci USA 2005; 102: 9866-9871.